Prognostic and Predictive Value of Gastric Acid Suppressants in the EORTC 1325/KEYNOTE-054 Randomized Phase III Trial of Pembrolizumab Vs Placebo in Resected Stage III Melanoma Emanuel Bührer , Nina Glassee , Michal Kicinski , Oliver J. Kennedy , Christian U. Blank , Georgina V. Long , Victoria G. Atkinson , Stéphane Dalle , Andrew M. Haydon , Andrey Meshcheryakov , Adnan Khattak , Matteo S. Carlino , Shahneen Sandhu , James Larkin , Susana Puig , Paolo A. Ascierto , Piotr Rutkowski , Dirk Schadendorf , Marye Boers-Sonderen , Anna Maria Di Giacomo , Alfonsus J.M. van den Eertwegh , Jean-Jacques Grob , Ralf Gutzmer , Rahima Jamal , Alexander C.J. van Akkooi , Sara Gandini , Sara Valpione , Stefan Suciu , Caroline Robert , Alexander M.M. Eggermont , Paul Lorigan , Mario Mandala EJC Skin Cancer（2025）
关键词
Immunotherapy, Immune-checkpoint inhibitors, Pembrolizumab, Gastric acid suppressants
AI 理解论文
溯源树
样例
